# Intravenous Iron vs. Oral Iron Supplementation for Postpartum Anemia

> **NCT05047211** · PHASE4 · COMPLETED · sponsor: **The University of Texas Medical Branch, Galveston** · enrollment: 40 (actual)

## Conditions studied

- Anemia, Iron Deficiency
- Delivery Complication

## Interventions

- **DRUG:** Ferrous sulfate
- **DRUG:** Iron dextran

## Key facts

- **NCT ID:** NCT05047211
- **Lead sponsor:** The University of Texas Medical Branch, Galveston
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-07
- **Primary completion:** 2023-03-15
- **Final completion:** 2023-04-15
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2023-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05047211

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05047211, "Intravenous Iron vs. Oral Iron Supplementation for Postpartum Anemia". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05047211. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*